Solventum Corp. (SOLV) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Solventum Corp. (SOLV) has a cash flow conversion efficiency ratio of 0.047x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($227.00 Million) by net assets ($4.80 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Solventum Corp. (SOLV) total market value for the company's overall valuation and market capitalisation.
Solventum Corp. - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how Solventum Corp.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Solventum Corp. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Solventum Corp. ranked by their cash flow conversion efficiency. Explore SOLV cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tryg A/S
CO:TRYG
|
0.056x |
|
Woori Financial Group Inc
NYSE:WF
|
0.380x |
|
PTC Inc
NASDAQ:PTC
|
0.075x |
|
SANDS CHINA ADR/1 O.N.
F:599
|
N/A |
|
Var Energi ASA
OL:VAR
|
36.298x |
|
Hanmi Semicon
KO:042700
|
0.128x |
|
Telus Corp
TO:T
|
0.064x |
|
Burlington Stores Inc
NYSE:BURL
|
0.136x |
Annual Cash Flow Conversion Efficiency for Solventum Corp. (2021–2025)
The table below shows the annual cash flow conversion efficiency of Solventum Corp. from 2021 to 2025. View SOLV stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $5.05 Billion | $369.00 Million | 0.073x | -81.75% |
| 2024-12-31 | $2.96 Billion | $1.19 Billion | 0.400x | +143.96% |
| 2023-12-31 | $11.67 Billion | $1.92 Billion | 0.164x | +14.80% |
| 2022-12-31 | $11.74 Billion | $1.68 Billion | 0.143x | -21.69% |
| 2021-12-31 | $12.06 Billion | $2.20 Billion | 0.183x | -- |
About Solventum Corp.
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressing… Read more